AI Tool Comparison
Comparing as AI Medical Research & Clinical Decision SupportGlass Health vs UpToDate
Glass Health
VS
UpToDate
Verdict by Category
Detailed Comparison
Feature
Glass Health
UpToDate
Pricing
FreemiumGlass Health publishes its pricing transparently:
Lite (Free): Basic clinical decision support and differential diagnosis with usage limits.
Starter at $20/month: Expanded ambient scribing and CDS features for regular clinical use.
Pro at $90/month: Extended ambient scribing, extended CDS, and extended Deep Reasoning for complex cases.
Max at $200/month: Maximum all features, priority response processing, and full EHR integration via SMART on FHIR (Epic, eClinicalWorks, athenahealth, Elation). Team plans available for group practices.
PaidUpToDate individual subscriptions start from $579/year for the core plan covering all clinical topics, drug information, CME/CE credits, and mobile access. UpToDate Pro Plus, which adds Expert AI and advanced medication decision support, is priced higher — exact pricing is displayed in the Wolters Kluwer online store at checkout after selecting country and profession.
Group plans for 2-19 clinicians offer discounted per-user rates available through the online store. Institutional licensing for hospitals and health systems is priced on request with dedicated implementation support, EHR integration, usage analytics, and enterprise management features.
Contact Wolters Kluwer through wolterskluwer.com/uptodate for institutional, group, and enterprise pricing.
Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Research & Education Tools
Summary
AI clinical decision support + ambient scribing in one workflow — real-time CDS and transparent pricing
Gold-standard clinical decision support for 2M+ clinicians — 13,000+ expert topics, Expert AI, and Best in KLAS
Glass Health Pros & Cons
Pros
- Only platform combining real-time Ambient CDS and ambient scribing in one unified clinical workflow
- Transparent published pricing (free to $200/mo) — rare in a category where most require sales conversations
- Evolving differential diagnosis during encounter — AI thinking partner not just a documentation tool
- SMART on FHIR EHR integration at Max tier — works natively inside Epic, eClinicalWorks, athenahealth, Elation
- Backed by Y Combinator, Initialized Capital, and Breyer Capital — strong early-stage pedigree
- Google for Startups AI First Accelerator alumnus (Apr 2024)
- Free Lite plan — no cost barrier for clinicians to evaluate real-time clinical AI support
Cons
- Early-stage company with ~$6.5M total funding — small vs OpenEvidence ($250M) or Doximity ($644M revenue)
- Max plan EHR integration at $200/month expensive for solo practitioners
- English-only — not suitable for multilingual clinical practices
- AI-generated differential not physician-reviewed like OpenEvidence or UpToDate content
- Less comprehensive clinical content than UpToDate’s 13,000+ expert-authored topics
- Small team (~7 employees) — limited engineering resources for product roadmap
UpToDate Pros & Cons
Pros
- Gold standard for 30+ years — most trusted clinical decision support resource used at 10,000+ hospitals globally
- Best in KLAS for Clinical Decision Support 4x (2021-2025) — highest independent healthcare technology rating
- Expert-authored and continuously updated — rigorously vetted by physician specialists, not AI-generated content
- UpToDate Expert AI (2026) — GenAI conversational layer grounded in expert clinical content, not general internet
- 10,000+ graded recommendations with transparent evidence levels — supports evidence-based clinical practice
- EHR integration with Epic and Cerner — clinical guidance accessible without leaving the patient record
- CME/CE/CPD credits earned while researching — turns clinical reference use into continuing education
Cons
- Expensive for individual subscribers — from $579/year before Expert AI features
- Expert AI (UpToDate Expert AI) only available on Pro Plus and trainee plans
- No real-time web search — content is updated editorially, not instantly from breaking research
- Institutional pricing requires direct negotiation — no self-serve enterprise option
- Interface feels traditional compared to newer AI-native tools like OpenEvidence
- Content is US-centric in focus despite global availability